Investing.com - Phio Pharma reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that was inline with expectations.
Phio Pharma announced earnings per share of $-0.260 on revenue of $12.5M. Analysts polled by Investing.com EPS of $-0.210 on revenue of $12.50M.
Phio Pharma 's are down 53.92% and is trading at $0.540 , still down 77.69% from its 52 week high of $2.42 set on Friday, April 8, 2022.
Phio Pharma follows other major Healthcare sector earnings this month
Phio Pharma's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar